GO:0005031 tumor necrosis factor receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005031 (tumor necrosis factor receptor activity) is a molecular function defined as combining with tumor necrosis factor (TNF), a proinflammatory cytokine produced by monocytes and macrophages, to initiate a change in cell function.
• TNF receptor activity is mediated by receptors such as TNFRSF1A (TNFR1/CD120a) and TNFRSF1B (TNFR2), which bind TNF and trigger downstream signaling [1,7].
• Soluble TNF receptors can act as decoys or biomarkers; for example, TNFR1 is selectively sequestered into Schwann cell extracellular vesicles where it functions as a TNFα decoy.
• Plasma soluble TNFR1 is a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients.
• Serum and urinary TNFR1 and TNFR2 concentrations have potential as markers of immunoglobulin A nephropathy activity.
• TNF receptor activity can be studied using binding assays, phosphorylation analysis, and CRISPR-based knockout or knock-in models to dissect receptor function [3,7].
Description
Tumor necrosis factor receptor (TNFR) activity, annotated as GO:0005031, is a molecular function that enables a cell to bind tumor necrosis factor (TNF), a proinflammatory cytokine produced by monocytes and macrophages, and thereby initiate a change in cell function. This activity is fundamental to inflammatory signaling and is mediated by specific cell-surface receptors such as TNFRSF1A (TNFR1, also known as CD120a or p55) and TNFRSF1B (TNFR2) [1,7]. The interaction between TNF and its receptors triggers diverse cellular responses, including proliferation, differentiation, apoptosis, and immune regulation, depending on the receptor and cellular context [3,7]. Researchers study TNFR activity to understand how inflammatory signals are transduced and how dysregulation contributes to disease. For example, TNF receptor binding and mitogenic action have been characterized in fibroblasts, where TNF can act as a growth factor. Phosphorylation of the TNFR1 (CD120a) intracellular domain recruits Bcl-2 and protects against apoptosis, illustrating how post-translational modifications modulate receptor function. Soluble forms of TNFR1 and TNFR2 are measurable in blood and urine and have been investigated as biomarkers of disease activity in conditions such as lupus nephritis and IgA nephropathy [2,6]. Additionally, TNFR1 can be packaged into extracellular vesicles to act as a decoy, sequestering TNFα and modulating inflammation in Schwann cells. Given its central role in inflammation and cell fate, TNFR activity is a target for basic and translational research. Understanding the molecular mechanisms, regulatory pathways, and disease associations of GO:0005031 requires robust experimental models, including CRISPR-engineered cell lines that allow precise manipulation of receptor genes [1,7].
tumor necrosis factor receptor activity At A Glance
| GO ID | GO:0005031 |
|---|---|
| GO term | tumor necrosis factor receptor activity |
| Ontology | molecular_function |
| Synonym | TNF receptor activity; tumor necrosis factor-activated receptor activity; TNF receptor activity, type I; TNF receptor activity, type II; NGF/TNF (6 C-domain) receptor activity |
| Major function | Binding to tumor necrosis factor (TNF) to initiate a change in cell function |
| Receptor examples | TNFRSF1A (TNFR1/CD120a/p55), TNFRSF1B (TNFR2) |
| Ligand | Tumor necrosis factor (TNF), a proinflammatory cytokine produced by monocytes and macrophages |
| Downstream outcomes | Proliferation, apoptosis, differentiation, inflammatory signaling |
| Disease relevance | Lupus nephritis, IgA nephropathy, inflammatory and autoimmune conditions |
What Is GO:0005031?
GO:0005031, tumor necrosis factor receptor activity, is defined as the molecular function of combining with tumor necrosis factor (TNF), a proinflammatory cytokine produced by monocytes and macrophages, to initiate a change in cell function. In other words, it is the ability of a receptor protein to bind TNF and transduce a signal that alters cellular behavior. This activity is associated with receptors such as TNFRSF1A and TNFRSF1B, which are activated by TNF binding and subsequently trigger intracellular signaling cascades [1,7].
Why Is tumor necrosis factor receptor activity Important in Cell Biology?
Tumor necrosis factor receptor activity is critically important because it mediates the cellular response to TNF, a master proinflammatory cytokine. This activity controls key cellular decisions such as survival, proliferation, and apoptosis, and its dysregulation is implicated in autoimmune diseases, chronic inflammation, and cancer [1,2,6,7]. Soluble TNF receptors are clinically useful biomarkers: plasma soluble TNFR1 reflects lupus nephritis activity in systemic lupus erythematosus, and serum and urinary TNFR1 and TNFR2 are potential markers of IgA nephropathy activity. Moreover, TNFR1 can be selectively packaged into extracellular vesicles to act as a TNFα decoy, revealing a novel regulatory mechanism with therapeutic implications. Thus, understanding GO:0005031 is essential for both basic immunology and clinical translation.
• Mediates the primary cellular response to the proinflammatory cytokine TNF [1,7].
• Regulates cell survival, apoptosis, and proliferation through TNFR1 and TNFR2 signaling [3,7].
• Soluble TNFR1 is a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus.
• Urinary and serum TNFR1 and TNFR2 are potential markers of IgA nephropathy activity.
• TNFR1 can function as a decoy when sequestered into extracellular vesicles, modulating TNFα availability.
• Phosphorylation of TNFR1 recruits Bcl-2 and protects against apoptosis, linking receptor modification to cell fate.
• TNF receptor binding and mitogenic action have been demonstrated in fibroblasts, showing context-dependent effects.
• TNF receptor activity is conserved across species, as shown by the cloning of an echinoderm TNFR.
• TWEAK/Fn14 signaling, related to the TNF receptor superfamily, influences tumor biology.
• Exercise-induced changes in TNF-alpha and soluble TNF-alpha receptors highlight physiological regulation.
Molecular Mechanism of tumor necrosis factor receptor activity
TNF Binding and Receptor Activation
In simple terms: TNF binds to its receptor on the cell surface, like a key fitting a lock, to start a signal inside the cell.
The molecular function GO:0005031 begins with the binding of tumor necrosis factor (TNF) to its receptor, such as TNFRSF1A (TNFR1) or TNFRSF1B (TNFR2). This interaction is highly specific and initiates a conformational change in the receptor that allows intracellular signaling [1,7]. TNF is a proinflammatory cytokine produced by monocytes and macrophages, and its binding to TNFRs can lead to diverse cellular outcomes depending on the receptor and cell type [3,7].
Receptor Phosphorylation and Recruitment of Adaptor Proteins
In simple terms: After TNF binds, the receptor gets tagged with phosphate groups, which attracts other proteins that relay the signal.
Phosphorylation of the tumor necrosis factor receptor CD120a (p55, also known as TNFR1) occurs on its intracellular domain and recruits Bcl-2, which protects against apoptosis. This post-translational modification is a key step in modulating the receptor's function and determining cell fate. The recruitment of Bcl-2 to the phosphorylated receptor highlights a direct link between TNFR activity and apoptotic regulation.
Soluble Receptor Decoy Function
In simple terms: Some TNF receptors are released from cells in small bubbles and act like sponges to soak up TNF, preventing it from triggering inflammation.
Tumor necrosis factor receptor-1 (TNFR1) can be selectively sequestered into Schwann cell extracellular vesicles, where it functions as a TNFα decoy. This means that instead of signaling, the receptor binds TNFα and neutralizes it, thereby modulating the inflammatory environment. This decoy function represents an important regulatory mechanism of TNFR activity.
Receptor Shedding and Soluble Forms
In simple terms: Receptors can be cut off from the cell surface and float in the blood, where they can still bind TNF and are measured as biomarkers.
Soluble forms of TNFR1 and TNFR2 are present in plasma and urine and can be measured as indicators of disease activity. For example, plasma soluble TNFR1 is a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients, and serum and urinary TNFR1 and TNFR2 are potential markers of IgA nephropathy activity. These soluble receptors can act as decoys or carriers for TNF, influencing its bioavailability [1,2,6].
Physiological Regulation of TNF and Soluble Receptors
In simple terms: The levels of TNF and its receptors change with age and exercise, showing that this system is dynamically regulated.
TNF-alpha and soluble TNF-alpha receptor responses differ between young and middle-aged males following eccentric exercise, indicating that physiological factors such as age and physical stress regulate this system. Such regulation can affect the availability of TNF and its binding to membrane-bound receptors, thereby modulating GO:0005031 activity.
Key Genes Involved in GO:0005031 tumor necrosis factor receptor activity
The following genes and proteins are directly involved in tumor necrosis factor receptor activity (GO:0005031) or its regulation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TNFRSF1A | Encodes TNFR1 (CD120a/p55), a receptor for TNF that mediates inflammatory and apoptotic signaling | Phosphorylation recruits Bcl-2 and protects against apoptosis; soluble form is a biomarker in lupus nephritis |
| TNFRSF1B | Encodes TNFR2, a receptor for TNF that mediates immune and survival signals | Soluble TNFR2 is a potential marker of IgA nephropathy activity |
| TNF | Encodes tumor necrosis factor, the proinflammatory cytokine ligand for TNFRs | TNF binding to receptors initiates changes in cell function [1,3] |
| BCL2 | Encodes Bcl-2, an anti-apoptotic protein recruited to phosphorylated TNFR1 | Recruited to phosphorylated CD120a to protect against apoptosis |
| TNFRSF12A | Encodes Fn14, a receptor for TWEAK in the TNF receptor superfamily | TWEAK/Fn14 signaling in tumors |
| TNFSF12 | Encodes TWEAK, a ligand related to TNF | TWEAK/Fn14 signaling in tumors |
| H. leucospilota TNFR | First cloned echinoderm TNFR, involved in immune response | Molecular characterization and functional analysis |
| NFKB1 | Encodes NF-kB p50 subunit, a downstream mediator of TNFR signaling | Canonical downstream pathway of TNFR activation |
| NFKB2 | Encodes NF-kB p52 subunit, involved in alternative TNFR signaling | Downstream mediator of TNFR signaling |
| MAPK1 | Encodes ERK2, a kinase in MAPK pathways activated by TNFR | Downstream signaling of TNFR |
| MAPK3 | Encodes ERK1, a kinase in MAPK pathways activated by TNFR | Downstream signaling of TNFR |
| JUN | Encodes c-Jun, a transcription factor activated by TNFR signaling | Downstream target of TNFR pathways |
| FADD | Encodes Fas-associated death domain protein, adaptor for TNFR1 apoptosis | Mediates TNFR1-induced apoptosis |
| TRADD | Encodes TNFR1-associated death domain protein, adaptor for TNFR1 | Key adaptor in TNFR1 signaling |
| TRAF2 | Encodes TNF receptor-associated factor 2, E3 ligase in TNFR signaling | Mediates TNFR1 and TNFR2 signaling |
| RIPK1 | Encodes receptor-interacting serine/threonine-protein kinase 1, key regulator of TNFR signaling | Controls cell survival and death downstream of TNFR1 |
How Is tumor necrosis factor receptor activity Regulated?
Tumor necrosis factor receptor activity is regulated at multiple levels. Receptor phosphorylation, as shown for CD120a (TNFR1), recruits Bcl-2 and modulates apoptotic signaling. Soluble forms of TNFR1 and TNFR2 can act as decoys or carriers, influencing TNF bioavailability [1,2,6]. Physiological states such as age and exercise alter TNF-alpha and soluble TNF-alpha receptor levels. Additionally, TNFR1 can be selectively packaged into extracellular vesicles to function as a TNFα decoy, providing a novel regulatory mechanism.
tumor necrosis factor receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TNFRSF1A | Lupus nephritis, systemic lupus erythematosus | Knockout or knock-in of TNFRSF1A in immune cell lines; measure sTNFR1 secretion |
| TNFRSF1A | IgA nephropathy | Overexpression or knockout in renal cell lines; assess TNFR1 shedding |
| TNFRSF1B | IgA nephropathy | Knockout or overexpression in renal cells; measure soluble TNFR2 |
| TNFRSF1A | Apoptosis regulation | Point mutation of phosphorylation sites in TNFRSF1A; assess Bcl-2 recruitment |
| TNFRSF12A | Tumor biology | Knockout or overexpression in cancer cell lines; study TWEAK/Fn14 signaling |
Lupus Nephritis and Systemic Lupus Erythematosus
Plasma soluble tumor necrosis factor receptor I (sTNFR1) is a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients. Elevated sTNFR1 levels reflect increased TNF signaling and are associated with renal involvement, making it a potential tool for monitoring disease activity.
IgA Nephropathy
Serum concentration and urinary excretion of tumor necrosis factor receptor 1 and 2 have been assessed as potential markers of immunoglobulin A nephropathy activity. These soluble receptors may help evaluate disease activity and guide clinical management.
Inflammatory and Autoimmune Conditions
TNF receptor activity is central to inflammatory signaling, and dysregulation can contribute to autoimmune conditions. TNFR1 can be sequestered into extracellular vesicles to act as a TNFα decoy, which may modulate inflammation in tissues such as peripheral nerves. Understanding these mechanisms could lead to new therapeutic strategies.
Cancer and Tumor Microenvironment
TWEAK/Fn14 signaling, a related TNF receptor superfamily pathway, plays a role in tumors. Although not directly GO:0005031, this highlights the broader importance of TNF receptor superfamily signaling in cancer biology.
From tumor necrosis factor receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TNFR1 phosphorylation regulate apoptosis? | Point mutation of phosphorylation sites in TNFRSF1A in cell lines |
| What is the role of soluble TNFR1 as a biomarker? | Knockout of TNFRSF1A in primary cells; measure soluble TNFR1 release |
| Can TNFR1 act as a decoy in extracellular vesicles? | Overexpression of tagged TNFRSF1A; isolate extracellular vesicles |
| How does TNFR2 contribute to IgA nephropathy? | Knockout or knock-in of TNFRSF1B in renal cell models |
| What is the function of TNFR in echinoderms? | Heterologous expression of cloned TNFR in mammalian cells |
| How do TNF-alpha and soluble receptors change with exercise? | In vivo human study; measure serum levels |
How to Study the tumor necrosis factor receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioligand binding assay | TNF binding affinity and receptor number | Characterize TNFR activity in fibroblasts |
| Immunoprecipitation/Western blot | Phosphorylation of TNFR1 and Bcl-2 recruitment | Study post-translational modification |
| Extracellular vesicle isolation | Presence of TNFR1 in vesicles | Investigate decoy function |
| ELISA | Soluble TNFR1 and TNFR2 concentrations | Biomarker assessment in lupus nephritis and IgA nephropathy [2,6] |
| Flow cytometry | Cell surface TNFR expression | Quantify receptor levels on immune cells |
| CRISPR knockout | Loss of receptor function | Determine causal role of TNFRs [1,7] |
| CRISPR knock-in | Tagged or mutant receptor expression | Track receptor localization and interactions |
| RNA-seq | Transcriptional changes downstream of TNFR activation | Identify signaling pathways |
Receptor Binding Assays
Radiolabeled or fluorescently labeled TNF can be used to measure binding affinity and receptor occupancy on cells expressing TNFRs. This method directly assesses the combining function defined in GO:0005031.
Phosphorylation Analysis
Immunoprecipitation followed by Western blotting with anti-phosphotyrosine antibodies can detect phosphorylation of TNFR1 (CD120a) and its interaction with Bcl-2.
Extracellular Vesicle Isolation and Analysis
Extracellular vesicles can be isolated from conditioned media by ultracentrifugation or affinity capture, and TNFR1 content can be analyzed by Western blot or ELISA to study decoy function.
ELISA for Soluble Receptors
Enzyme-linked immunosorbent assays (ELISAs) can quantify soluble TNFR1 and TNFR2 in plasma, serum, or urine, as used in biomarker studies for lupus nephritis and IgA nephropathy [2,6].
How CRISPR Can Be Used to Study GO:0005031 tumor necrosis factor receptor activity
Knockout
CRISPR knockout of TNFRSF1A or TNFRSF1B can eliminate receptor expression, allowing researchers to test the specific contribution of each receptor to TNF-induced signaling, apoptosis, and inflammatory responses [1,7]. Knockout models are essential for validating the role of GO:0005031 in disease contexts such as lupus nephritis.
Point Mutation
Point mutations can be introduced into specific phosphorylation sites of TNFRSF1A to dissect how phosphorylation regulates Bcl-2 recruitment and apoptosis. Such models help define the precise molecular determinants of receptor function.
Knock-in
Knock-in of tagged TNFR1 (e.g., GFP or HA tag) allows visualization and tracking of the receptor in live cells, including its packaging into extracellular vesicles. This approach can reveal novel trafficking and decoy functions.
Overexpression
Overexpression of TNFRSF1A or TNFRSF1B in cell lines can amplify receptor signaling and facilitate biochemical studies of downstream pathways [1,7]. Overexpression models are useful for studying receptor shedding and soluble receptor production [2,6].
How EDITGENE Supports tumor necrosis factor receptor activity Research
Researchers studying tumor necrosis factor receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor function, inflammatory signaling, or disease progression. Precise genetic models are essential to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for tumor necrosis factor receptor activity research.
Frequently Asked Questions About tumor necrosis factor receptor activity
What is tumor necrosis factor receptor activity?
Tumor necrosis factor receptor activity (GO:0005031) is a molecular function defined as combining with tumor necrosis factor (TNF), a proinflammatory cytokine produced by monocytes and macrophages, to initiate a change in cell function [1,7].
What genes are involved in tumor necrosis factor receptor activity?
Key genes include TNFRSF1A (TNFR1) and TNFRSF1B (TNFR2), which encode the receptors, and TNF, which encodes the ligand. Downstream signaling involves BCL2, TRADD, TRAF2, and RIPK1 [1,7].
How is tumor necrosis factor receptor activity regulated?
It is regulated by receptor phosphorylation, which recruits Bcl-2 and modulates apoptosis, and by soluble receptor decoys that bind TNF [1,2,6]. Physiological factors such as age and exercise also influence TNF and soluble receptor levels.
What diseases are associated with tumor necrosis factor receptor activity?
It is associated with lupus nephritis and systemic lupus erythematosus, IgA nephropathy, and inflammatory conditions where TNFR1 acts as a decoy.
How can I study tumor necrosis factor receptor activity in the lab?
Common methods include radioligand binding assays, phosphorylation analysis, ELISA for soluble receptors [2,6], and CRISPR knockout or knock-in models [1,7].
What is the role of soluble TNFR1 as a biomarker?
Plasma soluble TNFR1 is a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients, and serum and urinary TNFR1 are potential markers of IgA nephropathy activity.
Can TNFR1 act as a decoy?
Yes, TNFR1 can be selectively sequestered into Schwann cell extracellular vesicles where it functions as a TNFα decoy, neutralizing TNFα.
What is the difference between TNFR1 and TNFR2?
TNFR1 (TNFRSF1A) is also known as CD120a or p55 and can mediate apoptosis, while TNFR2 (TNFRSF1B) primarily mediates immune and survival signals. Both bind TNF and are annotated under GO:0005031 [1,7].
How does phosphorylation affect TNFR1?
Phosphorylation of the tumor necrosis factor receptor CD120a (p55) recruits Bcl-2 and protects against apoptosis.
Is tumor necrosis factor receptor activity conserved across species?
Yes, a tumor necrosis factor receptor has been cloned from the echinoderm Holothuria leucospilota, demonstrating evolutionary conservation.
Conclusion
Tumor necrosis factor receptor activity (GO:0005031) is a central molecular function that mediates cellular responses to the proinflammatory cytokine TNF. Its dysregulation is linked to autoimmune and inflammatory diseases, and soluble receptors serve as valuable biomarkers [1,2,6,7]. Understanding the mechanisms, regulation, and disease relevance of TNFR activity requires robust experimental models, including CRISPR-engineered cell lines. EDITGENE offers comprehensive services to support such research, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Sadri M et al.. 2022. Tumor necrosis factor receptor-1 is selectively sequestered into Schwann cell extracellular vesicles where it functions as a TNFα decoy.. Glia 70(2):256-272 PMID: 34559433
- 2. Liu XR et al.. 2023. Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients.. Ren Fail 45(1):2174355 PMID: 36946374
- 3. Vilcek J et al.. 1987. Tumor necrosis factor: receptor binding and mitogenic action in fibroblasts.. J Cell Physiol Suppl Suppl 5:57-61 PMID: 2824534
- 4. Hu G et al.. 2017. TWEAK/Fn14 signaling in tumors.. Tumour Biol 39(6):1010428317714624 PMID: 28639899
- 5. Li H et al.. 2019. The first cloned echinoderm tumor necrosis factor receptor from Holothuria leucospilota: Molecular characterization and functional analysis.. Fish Shellfish Immunol 93:542-550 PMID: 31394160
- 6. Miedziaszczyk M et al.. 2024. Assessment of serum concentration and urinary excretion of tumor necrosis factor receptor 1 and 2 and their potential as markers of immunoglobulin A nephropathy activity.. Adv Clin Exp Med 33(6):583-591 PMID: 37962255
- 7. Cottin V et al.. 2001. Phosphorylation of the tumor necrosis factor receptor CD120a (p55) recruits Bcl-2 and protects against apoptosis.. J Biol Chem 276(20):17252-60 PMID: 11278725
- 8. Arroyo E et al.. 2017. Tumor necrosis factor-alpha and soluble TNF-alpha receptor responses in young vs. middle-aged males following eccentric exercise.. Exp Gerontol 100:28-35 PMID: 29038027
